<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33782398</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>29</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>A haemagglutination test for rapid detection of antibodies to SARS-CoV-2.</ArticleTitle><Pagination><StartPage>1951</StartPage><MedlinePgn>1951</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1951</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-021-22045-y</ELocationID><Abstract><AbstractText>Serological detection of antibodies to SARS-CoV-2 is essential for establishing rates of seroconversion in populations, and for seeking evidence for a level of antibody that may be protective against COVID-19 disease. Several high-performance commercial tests have been described, but these require centralised laboratory facilities that are comparatively expensive, and therefore not available universally. Red cell agglutination tests do not require special equipment, are read by eye, have short development times, low cost and can be applied at the Point of Care. Here we describe a quantitative Haemagglutination test (HAT) for the detection of antibodies to the receptor binding domain of the SARS-CoV-2 spike protein. The HAT has a sensitivity of 90% and specificity of 99% for detection of antibodies after a PCR diagnosed infection. We will supply aliquots of the test reagent sufficient for ten thousand test wells free of charge to qualified research groups anywhere in the world.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Townsend</LastName><ForeName>Alain</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3702-0107</Identifier><AffiliationInfo><Affiliation>MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK. alain.townsend@imm.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK. alain.townsend@imm.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijal</LastName><ForeName>Pramila</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Tiong Kit</ForeName><Initials>TK</Initials><Identifier Source="ORCID">0000-0001-8746-8308</Identifier><AffiliationInfo><Affiliation>MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Kuan-Ying A</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0001-6891-6945</Identifier><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schimanski</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huo</LastName><ForeName>Jiandong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Structural Biology, The Rosalind Franklin Institute, Didcot, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Nimesh</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-9433-8448</Identifier><AffiliationInfo><Affiliation>Vaccine Immunology Laboratory, National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahikainen</LastName><ForeName>Rolle</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1265-862X</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matthews</LastName><ForeName>Philippa C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Infectious Diseases, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crook</LastName><ForeName>Derrick</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Infectious Diseases, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoosdally</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunachie</LastName><ForeName>Susanna</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5665-6293</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnes</LastName><ForeName>Eleanor</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-0860-0831</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Street</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conlon</LastName><ForeName>Christopher P</ForeName><Initials>CP</Initials><Identifier Source="ORCID">0000-0002-3531-2464</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frater</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7163-7277</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arancibia-C&#xe1;rcamo</LastName><ForeName>Carolina V</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudkin</LastName><ForeName>Justine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stoesser</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-4508-7969</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Infectious Diseases, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karpe</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neville</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6004-5433</Identifier><AffiliationInfo><Affiliation>Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ploeg</LastName><ForeName>Rutger</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7801-665X</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BRC Haematology Theme and Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamikanra</LastName><ForeName>Abigail A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsang</LastName><ForeName>Hoi Pat</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bown</LastName><ForeName>Abbie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Public Health England, Salisbury, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vipond</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Public Health England, Salisbury, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mentzer</LastName><ForeName>Alexander J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-4502-2209</Identifier><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Julian C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-0377-5536</Identifier><AffiliationInfo><Affiliation>Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwok</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0001-8928-5054</Identifier><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Screaton</LastName><ForeName>Gavin R</ForeName><Initials>GR</Initials><Identifier Source="ORCID">0000-0002-3549-4309</Identifier><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Medical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mongkolsapaya</LastName><ForeName>Juthathip</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3416-9480</Identifier><AffiliationInfo><Affiliation>Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dengue Hemorrhagic Fever Research Unit, Office for Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dejnirattisai</LastName><ForeName>Wanwisa</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Supasa</LastName><ForeName>Piyada</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klenerman</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dold</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Oxford Biomedical Research Centre, Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baillie</LastName><ForeName>J Kenneth</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0001-5258-793X</Identifier><AffiliationInfo><Affiliation>Genetics and Genomics, Roslin Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Shona C</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0001-8610-2806</Identifier><AffiliationInfo><Affiliation>NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Openshaw</LastName><ForeName>Peter J M</ForeName><Initials>PJM</Initials><Identifier Source="ORCID">0000-0002-7220-2555</Identifier><AffiliationInfo><Affiliation>National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semple</LastName><ForeName>Malcolm G</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0001-9700-0418</Identifier><AffiliationInfo><Affiliation>NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turtle</LastName><ForeName>Lance C W</ForeName><Initials>LCW</Initials><Identifier Source="ORCID">0000-0002-0778-1693</Identifier><AffiliationInfo><Affiliation>NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ainsworth</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allcock</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beer</LastName><ForeName>Sally</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0988-3458</Identifier><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bibi</LastName><ForeName>Sagida</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skelly</LastName><ForeName>Donal</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2426-3097</Identifier><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stafford</LastName><ForeName>Lizzy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeffrey</LastName><ForeName>Katie</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6506-2689</Identifier><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clutterbuck</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espinosa</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendoza</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Georgiou</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lockett</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallardo Sanchez</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scozzafava</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobrinodiaz</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thraves</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joly</LastName><ForeName>Etienne</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7264-2681</Identifier><AffiliationInfo><Affiliation>Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France. atnjoly@mac.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>200927</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>IS-BRC-1215-20013</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>HHSN272201400008C</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>110110Z/15/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>C18616/A25153</GrantID><Acronym>CRUK_</Acronym><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>200907</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>WT204969/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>095541/A/11/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>109965/Z/15/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/P021336/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L006588/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_19059</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>205228/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_19025</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000372" MajorTopicYN="N">Agglutination Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006386" MajorTopicYN="N">Hemagglutination Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019095" MajorTopicYN="N">Point-of-Care Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069078" MajorTopicYN="N">Seroconversion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>30</Day><Hour>7</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33782398</ArticleId><ArticleId IdType="pmc">PMC8007702</ArticleId><ArticleId IdType="doi">10.1038/s41467-021-22045-y</ArticleId><ArticleId IdType="pii">10.1038/s41467-021-22045-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Landsteiner K. On agglutination of normal human blood. Transfusion. 1961;1:5&#x2013;8. doi: 10.1111/j.1537-2995.1961.tb00005.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1537-2995.1961.tb00005.x</ArticleId><ArticleId IdType="pubmed">13758692</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz HP, Dorner F. Karl Landsteiner and his major contributions to haematology. Br. J. Haematol. 2003;121:556&#x2013;565. doi: 10.1046/j.1365-2141.2003.04295.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.2003.04295.x</ArticleId><ArticleId IdType="pubmed">12752096</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirst GK. The agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus. Science. 1941;94:22&#x2013;23. doi: 10.1126/science.94.2427.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.94.2427.22</ArticleId><ArticleId IdType="pubmed">17777315</ArticleId></ArticleIdList></Reference><Reference><Citation>Coombs RR, Mourant AE, Race RR. A new test for the detection of weak and incomplete Rh agglutinins. Br. J. Exp. Pathol. 1945;26:255&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2065689</ArticleId><ArticleId IdType="pubmed">21006651</ArticleId></ArticleIdList></Reference><Reference><Citation>Pamphilon DH, Scott ML. Robin Coombs: his life and contribution to haematology and transfusion medicine. Br. J. Haematol. 2007;137:401&#x2013;408. doi: 10.1111/j.1365-2141.2007.06531.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.2007.06531.x</ArticleId><ArticleId IdType="pubmed">17488485</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib I, et al. V(H)H (nanobody) directed against human glycophorin A: a tool for autologous red cell agglutination assays. Anal. Biochem. 2013;438:82&#x2013;89. doi: 10.1016/j.ab.2013.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ab.2013.03.020</ArticleId><ArticleId IdType="pubmed">23541519</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005;309:1864&#x2013;1868. doi: 10.1126/science.1116480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1116480</ArticleId><ArticleId IdType="pubmed">16166518</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R, et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444&#x2013;1448. doi: 10.1126/science.abb2762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020;181:894&#x2013;904 e899. doi: 10.1016/j.cell.2020.03.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.045</ArticleId><ArticleId IdType="pmc">PMC7144619</ArticleId><ArticleId IdType="pubmed">32275855</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan, J. et al. Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptor. 10.1101/2020.02.19.956235 (2020).</Citation></Reference><Reference><Citation>Tan, T. K. et al. A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses. 10.1101/2020.08.31.275701 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7822889</ArticleId><ArticleId IdType="pubmed">33483491</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls, A. C. et al. Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2. 10.1101/2020.08.11.247395 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604136</ArticleId><ArticleId IdType="pubmed">33160446</ArticleId></ArticleIdList></Reference><Reference><Citation>Zha, L. et al. Development of a COVID-19 vaccine based on the receptor binding domain displayed on virus-like particles. 10.1101/2020.05.06.079830 (2020).</Citation></Reference><Reference><Citation>Mulligan MJ, et al. Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586:589&#x2013;593. doi: 10.1038/s41586-020-2639-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2639-4</ArticleId><ArticleId IdType="pubmed">32785213</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai L, et al. A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS. Cell. 2020;182:722&#x2013;733 e711. doi: 10.1016/j.cell.2020.06.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.035</ArticleId><ArticleId IdType="pmc">PMC7321023</ArticleId><ArticleId IdType="pubmed">32645327</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, et al. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2020;586:572&#x2013;577. doi: 10.1038/s41586-020-2599-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2599-8</ArticleId><ArticleId IdType="pubmed">32726802</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanat F, et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat. Med. 2020;26:1033&#x2013;1036. doi: 10.1038/s41591-020-0913-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0913-5</ArticleId><ArticleId IdType="pubmed">32398876</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccoli L, et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell. 2020;183:1024&#x2013;1042.e21. doi: 10.1016/j.cell.2020.09.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.037</ArticleId><ArticleId IdType="pmc">PMC7494283</ArticleId><ArticleId IdType="pubmed">32991844</ArticleId></ArticleIdList></Reference><Reference><Citation>The National SARS-CoV-2 Serology Assay Evaluation Group, Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.&#xa0;The Lancet&#xa0;20, 1390&#x2013;1400 (2020)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7511171</ArticleId><ArticleId IdType="pubmed">32979318</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes CO, et al. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies. Cell. 2020;182:828&#x2013;842 e816. doi: 10.1016/j.cell.2020.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.025</ArticleId><ArticleId IdType="pmc">PMC7311918</ArticleId><ArticleId IdType="pubmed">32645326</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbiani DF, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020;584:437&#x2013;442. doi: 10.1038/s41586-020-2456-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2456-9</ArticleId><ArticleId IdType="pmc">PMC7442695</ArticleId><ArticleId IdType="pubmed">32555388</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction. Nat. Biotechnol. 2020;38:1073&#x2013;1078. doi: 10.1038/s41587-020-0631-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-020-0631-z</ArticleId><ArticleId IdType="pubmed">32704169</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruse, R. L. et al. A rapid, point of care red blood cell agglutination assay for detecting antibodies against SARS-CoV-2. 10.1101/2020.05.13.094490 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7959259</ArticleId><ArticleId IdType="pubmed">33773139</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto D, et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020;583:290&#x2013;295. doi: 10.1038/s41586-020-2349-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2349-y</ArticleId><ArticleId IdType="pubmed">32422645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegmann TG, Smithies O. A simple hemagglutination system requiring small amounts of red cells and antibodies. Transfusion. 1966;6:67&#x2013;73. doi: 10.1111/j.1537-2995.1966.tb04696.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1537-2995.1966.tb04696.x</ArticleId></ArticleIdList></Reference><Reference><Citation>ter Meulen J, et al. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med. 2006;3:e237. doi: 10.1371/journal.pmed.0030237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0030237</ArticleId><ArticleId IdType="pmc">PMC1483912</ArticleId><ArticleId IdType="pubmed">16796401</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo J, et al. Neutralization of SARS-CoV-2 by destruction of the prefusion spike. Cell Host Microbe. 2020;28:497. doi: 10.1016/j.chom.2020.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.07.002</ArticleId><ArticleId IdType="pmc">PMC7480219</ArticleId><ArticleId IdType="pubmed">32910920</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, K.-Y. A. et al. Plasmablast-derived antibody response to acute SARS-CoV-2 infection in humans. 10.1101/2020.08.28.267526 (2020).</Citation></Reference><Reference><Citation>Huo J, et al. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. Nat. Struct. Mol. Biol. 2020;27:846&#x2013;854. doi: 10.1038/s41594-020-0469-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-0469-6</ArticleId><ArticleId IdType="pubmed">32661423</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, et al. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient. Nat. Struct. Mol. Biol. 2020;27:950&#x2013;958. doi: 10.1038/s41594-020-0480-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-0480-y</ArticleId><ArticleId IdType="pubmed">32737466</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D, et al. Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies. Cell. 2020;181:1436&#x2013;1441. doi: 10.1016/j.cell.2020.05.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.047</ArticleId><ArticleId IdType="pmc">PMC7289117</ArticleId><ArticleId IdType="pubmed">32531248</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y, et al. Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 2020;21:1336&#x2013;1345. doi: 10.1038/s41590-020-0782-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0782-6</ArticleId><ArticleId IdType="pubmed">32887977</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams ER, et al. Antibody testing for COVID-19: a report from the National COVID Scientific Advisory Panel. Wellcome Open Res. 2020;5:139. doi: 10.12688/wellcomeopenres.15927.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.15927.1</ArticleId><ArticleId IdType="pmc">PMC7941096</ArticleId><ArticleId IdType="pubmed">33748431</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson, K. E. et al. Infectious Diseases Society of America Guidelines on the diagnosis of COVID-19: serologic yesting. Clin. Infect. Dis., ciaa1343&#xa0;(2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543294</ArticleId><ArticleId IdType="pubmed">32918466</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend, A., Rijal, P., Tan, T. K. &amp; Joly, E. A haemagglutination test for rapid detection of antibodies to SARS-CoV-2. Protocol Exchange10.21203/rs.3.pex-1367/v1 (2021).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>